Schlafapnoe & Herzschwäche

Der häufigste Grund stationärer Behandlungen in Deutschland ist unverändert die Herzschwäche (Herzinsuffizienz). Diese betrifft nach Analysen des Kompetenzzentrums Herzinsuffizienz ungefähr 3 Millionen Menschen in Deutschland. Frauen leiden häufiger an einer Herzschwäche mit erhaltener systolischer Funktion (heart failure with preserved ejection fraction, HF-PEF; diastolische Herzinsuffizienz), Männer häufiger an einer systolischen Herzschwäche (heart failure with reduced ejection fraction, HF-REF; 1).

• References

• 1 Task Force Members. McMurray JJV, Adamopoulos S. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Eur Heart J 2012; 33: 1787-847.
• 2 Oldenburg O, Lamp B, Faber L. et al. Sleep disordered breathing in patients with symptomatic heart failure. Eur J Heart Failure 2007; 9: 251-257.
• 3 Schulz R, Blau A, Börgel J. et al. Sleep apnoea in heart failure. Eur Respir J 2007; 29: 1201-1205
• 4 Damy T, Margarit L, Noroc A. et al. Prognostic impact of sleep-disordered breathing and its treatment with nocturnal ventilation for chronic heart failure. Eur J Heart Failure 2012; 14: 1009-1019.
• 5 Jilek C, Krenn M, Sebah D. et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Failure 2010; 13: 68-75.
• 6 Levy P, Ryan S, Oldenburg O, Parati G. Sleep apnoea and the heart. Eur Resp Rev 2013; 2: 333-352.
• 7 Oldenburg O. Cheyne-Stokes respiration in chronic heart failure. Treatment by adaptive servoventilation. Circ J 2012; 76: 2305-2317
• 8 Yumino D, Redolfi S, Ruttanaumpawan P. et al. Nocturnal rostal fluid shift. A unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598-1605
• 9 Yumino D, Wang H, Floras JS. et al. Prevalence and Physiological Predictors of Sleep Apnea in Patients With Heart Failure and Systolic Dysfunction. J Card Fail 2009; 15: 279-285.
• 10 Guazzi M, Raimondo R, Vincenzi M. et al. Exercise oscillatory ventilation may predict sudden cardiac death in heart failure patients. J Am Coll Cardiol 2007; 50: 299-308.
• 11 Guazzi M. Treating exercise oscillatory ventilation in heart failure: the detail that may matter. Eur Resp J 2012; 40: 1075-1077.
• 12 Bitter T, Westerheide N, Hossain MS. et al. Symptoms of sleep apnoea in chronic heart failure – results from a prospective cohort study in 1,500 patients. Sleep Breath 2012; 16: 781-791.
• 13 Lanfranchi P, Braghiroli A, Bosimini E. et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440.
• 14 Lanfranchi P, Somers V, Braghiroli A. et al. Central sleep apnea in left ventricular dysfunction. Prevalence and implications for arrhythmic risk. Circulation 2003; 107: 727-732.
• 15 Jaffe LM, Kjekshus J, Gottlieb SS. Importance and management of chronic sleep apnoea in cardiology. Eur Heart J 2013; 34: 809-815.
• 16 Arzt M, Young T, Finn L. et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Ann Intern Med 2006; 166: 1716-1722.
• 17 Oldenburg O, Faber L, Vogt J. et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Failure 2007; 9: 820-826
• 18 Efken C, Bitter T, Prib N. et al. Obstructive sleep apnoea: longer respiratory event lengths in patients with heart failure. Eur Resp J 2012; 41: 1340-1346.
• 19 Wedewardt J, Bitter T, Prinz C. et al. Cheyne-Stokes respiration in heart failure: cycle length is dependent on left ventricular ejection fraction. Sleep Med 2010; 11: 137-142.
• 20 Woehrle H, Graml A, Weinreich G. Age-$$$$ and gender-dependent adherence with continuous positive airway pressure therapy. Sleep Med 2011; 12: 1034-1036.
• 21 Kasai T, Narui K, Dohi T. et al. Prognosis of patients with heart failure and obstructive sleep apnea treated wtih continuous positive airway pressure. Chest 2008; 133: 690-696.
• 22 Wang H, Parker J, Newton G. et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 49: 1625-1631.
• 23 Krachman S, Nugent T, Crocetti J, D’Alonzo G, Chatila W. Effects of oxygen therapy on left ventricular function in patients with Cheyne-Stokes respiration and congestive heart failure. J Clin Sleep Med 2005; 15: 271-276.
• 24 Lorenzi-Filho G, Rankin F, Bies I, Bradley T. Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999; 159: 1490-1498.
• 25 Sakakibara M, Sakata Y, Usui K. et al. Effectiveness of short-term treatment with nocturnal oxygen therapy for central sleep apnea in patients with congestive heart failure. J Cardiol 2005; 46: 53-61.
• 26 Sasayama S, Izumi T, Seino Y, Ueshima K, Asanoi H. CHFHOT Study Group. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and Cheyne-Stokes respiration. Circ J 2006; 70: 1-7.
• 27 Sasayama S, Izumi T, Matsuzaki M. et al. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J 2009; 73: 1255-1262.
• 28 Staniforth A, Kinnear W, Starling R. et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19: 922-928.
• 29 Kaneko Y, Floras J, Usui K. et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241.
• 30 Bradley T, Logan A, Kimoff R. et al. Continuous positive airway pressure for central sleep apnea and heart failure. NEJM 2005; 353: 2025-2033.
• 31 Arzt M, Floras J, Logan A. et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure. Circulation 2007; 115: 3173-3180.
• 32 Kasai T, Narui K, Dohi T. et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with Cheyne-Stokes respiration and central sleep apnea. Circ J 2005; 69: 913-921.
• 33 Johnson K, Johnson D. Bilevel positive airway pressure worsens central apneas during sleep. Chest 2005; 128: 2141-2150.
• 34 Dohi T, Kasai T, Narui K. et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ J 2008; 72: 1100-1105.
• 35 Kasai T, Kasagi S, Maeno Ki. et al. Adaptive Servo-Ventilation in Cardiac Function and Neurohormonal Status in Patients With Heart Failure and Central Sleep Apnea Non-responsive to Continuous Positive Airway Pressure. JACC Heart Failure 2013; 1: 58-63.
• 36 Teschler H, Döhring J, Wang Y-M, Berthon-Jones M. Adaptive pressure support servoventilation. A novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001; 164: 614-619.
• 37 Aurora R, Chowdhuri S, Ramar K. et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evdence-based literature review and meta-analysis. Sleep 2012; 35: 17-40.
• 38 Sharma B. et al. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 2012; 142: 1211-1221
• 39 Oldenburg O, Schmidt A, Lamp B. et al. Adaptive servoventilation improves cardiac function in patients with chronic heart failure and Cheyne-Stokes respiration. Eur J Heart Failure 2008; 10: 581-586.
• 40 Oldenburg O, Bitter T, Lehmann R. et al. Adaptive servoventilation improves cardiac function and respiratory stability. Clin Res Cardiol 2011; 100: 107-115.
• 41 Bitter T, Gutleben KJ, Nölker G. et al. Treatment of Cheyne-Stokes Respiration Reduces Arrhythmic Events in Chronic Heart Failure. J Cardiovasc Electrophysiol. 2013 Jun 5. doi: [Epub ahead of print]